Paul Hartmann AG (DB: PHH2)
Health Care · Health Care Equipment & Supplies · DE
€200.00
+0.50% today · -15.0% 1Y
Paul Hartmann AG (DB: PHH2) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $825.12M.
Over the last twelve months the share price has lost 15.0%, trading between 197.50 and 235.00.
Tweenvest scores Paul Hartmann AG across four factors: quality 75/100, value 68/100, growth 16/100, dividend 90/100. Its strongest factor is dividend.
PHH2 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $825.12M
- Revenue (TTM)
- $2.84B
- P/E
- 7.07
- EPS
- 28.13
- Dividend yield
- 4.02%
- Beta (5Y)
- 0.48
- 52-week high
- €235.00
- 52-week low
- €197.50
- Avg volume (3M)
- —
- Shares outstanding
- 3.55M
- Employees
- —
- Next earnings
- —
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.